MarketPeel
Insider Trading Intelligence
RL

Ra Capital Nexus Fund Iv, L.p.

COAG
DIRECTOR · HEMAB THERAPEUTICS HOLDINGS, INC. · CIK 0002053586
FILING MIX · LIFETIME60%/40%
BUYS
9
SELLS
6
TOTAL VALUE
$52.22M
COMPANIES
1
ACTIVE SINCE
May 2026
HOLDINGS NOW
6,261,118
AVG SELL PX
TRADE KIND
SHOWING 15 / 15
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 18 pending
Forward-return performance of every backtestable P/S trade by Ra Capital Nexus Fund Iv, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%+5.48%+2.04%+3.45%+1.61%
14d3+100.00%+8.10%+3.38%+3.76%+3.76%
30d3(3 pending)
60d3(3 pending)
90d3(3 pending)
180d3(3 pending)
1y3(3 pending)
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COAG · 6,261,118 shares · as of May 6, 2026
01,578,6313,157,2634,735,8946,314,525SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
FLOW · 9 buys / 6 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
53,407$24.83$1.33M6,314,525May 6, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
14,611$23.77$347.3K6,261,118May 6, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
10,268$25.00$256.7K6,246,507May 5, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
87,143$24.59$2.14M6,236,239May 5, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
2,541,250$18.00$45.74M6,149,096May 4, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
27,7200May 4, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
64,6800May 4, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
42,3410May 4, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
56,9720May 4, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
18,1460May 4, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
10,0540May 4, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
3,607,8463,607,846May 4, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
133,750$18.00$2.41M354,938May 4, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
221,188221,188May 4, 2026May 6, 2026
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
1,009,0521,009,052May 4, 2026May 6, 2026
Other insiders · COAG
Loading peer insiders…
About this filer
CIK 0002053586
ROLE
Director
PRIMARY
COAG
COMPANIES
1
ACTIVE SINCE
May 2026
MARKETPEEL · /INSIDER/0002053586DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback